Ironwood Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowe…

Drug Manufacturers - Specialty & Generic
US, Boston [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Ironwood Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Ironwood Pharmaceuticals, Inc. has no acquisition track records yet.

End of IRWD's Analysis
CIK: 1446847 CUSIP: 46333X108 ISIN: US46333X1081 LEI: - UEI: -
Secondary Listings
IRWD has no secondary listings inside our databases.